收藏 | 手机打开

Safety and pharmacokinetics of MRX-I at therapeutic and supratherapeutic doses in healthy Chinese subjects and assessment of MRX-I dosing regimens based on pharmacokinetic-pharmacodynamic analysis

Junzhen Wu  Hailan Wu  Yu Wang  Yuancheng Chen  Beining Guo  Guoying Cao  Xiaojie Wu  Jicheng Yu  Jufang Wu  Hong Yuan  Jing Zhang  
【摘要】:Objectives:To assess the safety and pharmacokinetics of a new-generation oxazolidinone MRX-I and a major inactive metabolite M2 after single oral administration of 800,1200 and 1600 mg under the fed condition;and to evaluate three dosing regimens against methicillin-resistant Staphylococcus aureus(MRSA) infections based on pharmacokinetic/pharmacodynamic(PK/PD) analysis.Methods:Twenty healthy subjects received a single oral dose of 1200 or 1600 mg of MRX-I or placebo under fed condition in a double blind,placebo-controlled dose escalation tolerance study.Fifty-two subjects received single doses of 800 mg of MRX-I under fed condition in a blinded,randomized,single-center,four-periods,4-crossover thorough QT study.Noncompartmental analysis were used to evaluate the pharmacokinetics of MRX-I and M2.Steady-state concentrations of MRX-I following different dosing regimens(800,1200,and 1600 mg every 12 h) were simulated employed a newly developed two-compartment PK model.The minimum inhibitory concentration distribution of MRX-I was analyzed in 348 Staphylococci clinical isolates.Monte Carlo simulations were conducted to attain probability of target attainment(PTA),and cumulative fraction of response(CFR) to predict the efficacy of the three regimens.Results:All three doses ranging from 800 to 1600 mg of MRX-I were well tolerated in the healthy subjects under fed condition,and nonlinear PK was observed after single oral administration(Table 1,Table 2,Table 3 and Figure 1).The mean plasma exposure of M2 to that of MRX-I exceeded 10% in the three groups.Both MIC_(50) and MIC_(90)(MICs to inhibit the growth of 50 and 90% of microorganisms,respectively) of MRX-I against MRSA were 0.5 mg/L(Table 4).PK/PD analysis and Monte Carlo simulations predicted that 800 mg q12 h was efficacious against infections caused by MRSA with an MIC≤1 mg/L(PTA90% and CFR90%)(Figure 2).Conclusions:MRX-I is a safe option against MRSA even at a suprathepeutic dose of 1600 mg.The regimen of 800 mg q 12 h could achieve great efficacy for the bacterial infections caused by MRSA.The is the first PK/PD study to predict 800 mg q 12 h is sufficient to treat MRSA infections with an MIC≤1 mg/L.A Phase Ⅲ study with this suggested dosing regimen is being conducted.

中国期刊全文数据库 前20条
1 Qian Zhang;Mei-Fang Chu;Yan-Hong Li;Chun-Hua Li;Run-Jia Lei;Si-Cen Wang;Bao-Jun Xiao;Jian-Gang Yang;;Quantitative analysis by reversed-phase high-performance liquid chromatography and retinal neuroprotection after topical administration of moxonidine[J];International Journal of Ophthalmology;2020年03期
2 ;Large-scale Facilities for Astronomical Observation[J];Bulletin of the Chinese Academy of Sciences;2019年04期
3 Zhichang Wang;Jun Hu;Wenyong Zheng;Tao Yang;Xinkai Wang;Chunlin Xie;Xianghua Yan;;Lactobacillus frumenti mediates energy production via fatty acid β-oxidation in the liver of early-weaned piglets[J];Journal of Animal Science and Biotechnology;2020年01期
4 Yang Zhiqiang;Lu Yanchun;Zhou Jing;Xu Dongying;He Wen;Peng Chong;Tan Dejin;;Toxicity and Field Efficacy Test of Several Insecticides against Carsidara marginalis Walker[J];Plant Diseases and Pests;2020年01期
5 LI Xin-Gang;NI Jian;SHEN Su;WANG Xiao-Ping;TIAN Jing-Chen;;Pharmacokinetic interaction of Forsythia suspensa extract and azithromycin injection after single and co-intravenous administration in rats[J];Chinese Journal of Natural Medicines;2020年03期
6 ;China Industrial Economics[J];China Economist;2020年03期
7 Xiaotong Yang;Xianchun Chen;Ting Lei;Lin Qin;Yang Zhou;Chuan Hu;Qingfeng Liu;Huile Gao;;The construction of in vitro nasal cavity-mimic M-cell model,design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration[J];Acta Pharmaceutica Sinica B;2020年06期
8 ;China Industrial Economics[J];China Economist;2020年04期
9 ;China Industrial Economics[J];China Economist;2019年06期
10 Lu Yi-tong;Qi Lian-wen;Xu Qian-qian;Ding Liang-jun;Wang Bo;Liu Hai-rui;Li Ji-chang;;Pharmacokinetics of Milbemycin Oxime in Dogs Following Its Intravenous and Oral Administration[J];Journal of Northeast Agricultural University(English Edition);2018年01期
11 Liqiong Niu;Qu Chen;Canfeng Hua;Yali Geng;Liuping Cai;Shiyu Tao;Yingdong Ni;Ruqian Zhao;;Effects of chronic dexamethasone administration on hyperglycemia and insulin release in goats[J];Journal of Animal Science and Biotechnology;2018年03期
12 ;Introduction to China City Planning Review[J];China City Planning Review;2017年01期
13 Jin Zhang;Paloma Valverde;Xiaofang Zhu;Dana Murray;Yuwei Wu;Liming Yu;Hua Jiang;Michel M Dard;Jin Huang;Zhiwei Xu;Qisheng Tu;Jake Chen;;Exercise-induced irisin in bone and systemic irisin administration reveal new regulatory mechanisms of bone metabolism[J];Bone Research;2017年01期
14 ;Introduction to China City Planning Review[J];China City Planning Review;2017年02期
15 Chen Hongyan;;A Review and Critique of Discourse Mode of Public Administration Slogans——Based on the Study of Postmodern Public Administration Discourse Theory[J];学术界;2017年08期
16 ;China Industrial Economics[J];China Economist;2017年05期
17 Chang Yaowen;Li Fenqiang;Wang Wenhui;Song Laichang;Li Li;Li Zhengfei;Su Dongjun;Fu Zhaoliang;;Integrated treatment for lower-limb stage Ⅱ thromboangiitis obliterans by interventional therapy and oral administration of Chinese medicine: a randomized controlled clinical trial[J];Journal of Traditional Chinese Medicine;2015年01期
18 Akihiko Sakatani;Yoshinori Doi;Takaaki Matsuda;Yasutaka Sasai;Naohiro Nishida;Megumi Sakamoto;Naoto Uenoyama;Yoshiya Matsumoto;Kazuo Kinoshita;;Protracted anaphylaxis developed after peginterferon α-2a administration for chronic hepatitis C[J];World Journal of Gastroenterology;2015年09期
19 Cedillo J;Kholif AE;Salem AZM;Elghandour MMY;Vázquez JF;Alonso MU;Barbabosa A;Chagoyán JCV;Reyna AG;;Oral administration of Sauce llorón extract to growing lambs to control gastrointestinal nematodes and Moniezia spp.[J];Asian Pacific Journal of Tropical Medicine;2015年07期
20 Yeshwant Singh;Mahendra Kumar Hidau;Shio Kumar Singh;;Rifabutin reduces systemic exposure of an antimalarial drug 97/78 upon co-administration in rats:an in-vivo & in-vitro analysis[J];Asian Pacific Journal of Tropical Medicine;2015年08期
中国重要会议论文全文数据库 前10条
1 Junzhen Wu;Hailan Wu;Yu Wang;Yuancheng Chen;Beining Guo;Guoying Cao;Xiaojie Wu;Jicheng Yu;Jufang Wu;Hong Yuan;Jing Zhang;;Safety and pharmacokinetics of MRX-I at therapeutic and supratherapeutic doses in healthy Chinese subjects and assessment of MRX-I dosing regimens based on pharmacokinetic-pharmacodynamic analysis[A];2018年中国药理学会定量药理学专业委员会学术年会论文集[C];2018年
2 Xueting Yao;Pangke Yan;Nan Wu;Shiping Ma;Ji Jiang;Dongyang Liu;Pei Hu;;A Physiologically Based Pharmacokinetic Model of HSK3486 and Extrapolation to Special Populations and Drug-Drug Interactions[A];2018年中国药理学会定量药理学专业委员会学术年会论文集[C];2018年
3 Feli M Walther;Mark J Allan;Rainer KA Roepke;Martin C Nuernberger;;Safety of fluralaner chewable tablets(Bravecto ~(TM)),a novel systemic antiparasitic drug,in dogs after oral administration[A];中国畜牧兽医学会兽医药理毒理学分会第十五次学术讨论会论文集[C];2019年
4 Feng Zhang;Mingping La;Xiaobin Gong;Shouhong Gao;Zhijun Wu;Lianna Sun;Xia Tao;Wansheng Chen;;Metabolites identification and pharmacokinetic study of Lamiophlomis rotata in rat[A];第六届全国治疗药物监测学术年会论文摘要集[C];2016年
5 zhang chengliang;;Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions:a comprehensive study[A];第六届全国治疗药物监测学术年会论文摘要集[C];2016年
6 Sai Li;Xiaoyan Sheng;Zaijun Zhang;Yuqiang Wang;Xin Zhang;Xiaomin Wen;Pei Yu;Kang Peng;;Concurrent determination of Danshensu and hydroxyl ligustrazine in rat plasma using high-performance liquid chromatography and its application to the pharmacokinetic study of ADTM, DSS and TMP-OH following intravenous administration[A];2020第25届广东省药师周大会论文集[C];2019年
7 苏悦;Xiaoqing Yan;Xia Fan;Qiaoxia Dai;Yi Tang;Chao Zheng;;GLP-1 receptor agonist(GLP1RA)liraglutide promotes neovascularization by improving the function of endothelial progenitor cells[A];第三届中国生物物理学会代谢生物学分会学术研讨会论文集[C];2019年
8 Zhang xianhua;Huang Xi;;Pharmacokinetic and pharmacodynamic study of DCH extract after oral administration[A];第二届国际抑郁共病暨第十二届中国中西医结合基础理论学术研讨会论文集[C];2016年
9 Shu Liu;Rongxin Chen;Tao Liu;Xiaoquan Lin;Xiaohua Zeng;Chuanzhong Lin;Hongbing Huang;;Investigation of drug administration times in conventional intestinal cancer therapy and chronotherapy review[A];2016年广东省药师周大会论文集[C];2015年
10 ;Potentiating effect of diltiazem on pentobarbital hypnosis may be related to the 5-HT_(1A) and 5-HT_(2A/2C) receptors[A];中国药理学会第十次全国学术会议专刊[C];2009年
中国博士学位论文全文数据库 前10条
1 傅长吉;管理的人性本质[D];吉林大学;2006年
2 曹欢;县级政府行政成本研究[D];西南大学;2011年
3 张世杰;公共治理机制:实现责任行政的途径[D];吉林大学;2008年
4 葛圣金;监测麻醉与镇静深度的新方法-ARX模式听觉诱发电位指数[D];复旦大学;2003年
5 乔风;[D];华中科技大学;2011年
6 黄晓东;社会资本视域下的政府治理问题研究[D];吉林大学;2009年
7 郭冬梅;行政人格及其塑造[D];河北师范大学;2009年
8 Philip Allen McBrayer;[D];华中师范大学;2005年
9 唐云彪;FY-10与左羟丙哌嗪药代动力学研究[D];吉林大学;2007年
10 刘雪华;论公共管理的公共性——一种公共权力的视角[D];吉林大学;2004年
中国硕士学位论文全文数据库 前10条
1 林淑玲;高职院校教务信息管理系统的分析与设计[D];华北电力大学(河北);2010年
2 高山;国家安全至上—小布什政府全球能源战略浅析[D];外交学院;2011年
3 罗琳;美国公共管理硕士教育及对中国的借鉴意义[D];外交学院;2006年
4 王红;企业简介翻译实践报告[D];天津大学;2015年
5 唐重华;高校廉政文化建设研究[D];兰州大学;2009年
6 陈百忠;奥巴马政府“重返亚太”战略的分析[D];上海外国语大学;2013年
7 董继栋;软权力与冷战后美国对拉美的外交政策[D];外交学院;2010年
8 黄敏森;论行政合同[D];长春理工大学;2008年
9 姜柳;公共管理类论文Networks in Public Administration Scholarship和Public Administration in Dark Times英汉翻译实践报告[D];黑龙江大学;2016年
10 陈琳;论我国行政问责制的法制化[D];吉林大学;2009年
中国重要报纸全文数据库 前2条
1 ;崛起在红土高原的“新星”[N];国际商报;2004年
2 易水;新词集锦(376)[N];计算机世界;2003年
 快捷付款方式  订购知网充值卡  订购热线  帮助中心
  • 400-819-9993
  • 010-62982499
  • 010-62783978